Pharvaris NV（PHVS）价格预测PHVSPharvaris NV

Alphio's PHVS stock price prediction model matches the current Pharvaris NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $32.22 (+0.86%). The 1-week path is $32.46 (+1.60%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Pharvaris NV (PHVS) is a good buy right now due to its recent Phase 3 trial success for its drug deucrictibant, which achieved an 83% reduction in monthly HAE attacks. The stock has shown strong momentum with a 5-day change of +13.23% and a current RSI of 61.35, suggesting bullish momentum. Additionally, analysts have set a price target range of $40 to $65, indicating potential upside of 27% to 106% from the current price. The main risk is the company's ongoing net losses, which totaled €47.8 million in Q2 2026, reflecting the need for continued financial improvement.

Pharvaris NV (PHVS) last closed at $31.9500008, gaining +1.30%. These facts feed the 1-day and 1-week PHVS price prediction above.